Polar Capital’s Juno Therapeutics, Inc. JUNO Stock Holding History

Polar Capital’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-37,500	Closed	-$1.71M	–	290
2017 Q4	$1.71M	Buy	+37,500	New	+$1.87M	0.02%	237

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Polar Capital's JUNO Position: Q1 2018 in Review

Polar Capital sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 37,500 shares — an estimated $1.71M sold.

Polar Capital first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $1.71M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Polar Capital reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Polar Capital sold 37,500 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.71M.
Polar Capital first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Polar Capital's Juno Therapeutics, Inc. position peaked at $1.71M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Polar Capital's 13F filing for Q1 2018, filed 15 May 2018.